Mühlbacher, M <br/><br/>
Intravenous mirtazapine is safe and effective in the treatment of depressed inpatients.  [electronic resource] 

 -  Neuropsychobiology  2006 
 - 83-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0302-282X 
<br/><br/><label>Standard No.: </label>10.1159/000091724  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antidepressive Agents, Tricyclic--administration & dosage<br/>Depressive Disorder, Major--diagnosis<br/>Fatigue--chemically induced<br/>Female<br/>Headache--chemically induced<br/>Humans<br/>Injections, Intravenous<br/>Inpatients<br/>Male<br/>Mianserin--administration & dosage<br/>Middle Aged<br/>Mirtazapine<br/>Nausea--chemically induced<br/>Psychiatric Status Rating Scales<br/>Severity of Illness Index<br/>Statistics, Nonparametric<br/>Treatment Outcome<br/>Vertigo--chemically induced